Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion

IMPORTANCE: Expanding Medicaid eligibility could affect prescriptions of buprenorphine with naloxone, an established treatment for opioid use disorder, and opioid pain relievers (OPRs). OBJECTIVE: To examine changes in prescriptions of buprenorphine with naloxone and OPRs after the US Affordable Car...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Main Authors: Saloner, Brendan, Levin, Jonathan, Chang, Hsien-Yen, Jones, Christopher, Alexander, G. Caleb
Formato: Artigo
Idioma:Inglês
Publicado: American Medical Association 2018
Assuntos:
Original Investigation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324520/
https://ncbi.nlm.nih.gov/pubmed/30646116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.1588
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares